Twist Bioscience (TWST) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Twist Bioscience (TWST) is Neutral.

The composite score behind that read is +0.18, weighing +0.27 of bullish evidence against -0.19 bearish.

Twist Bioscience last closed at $159.78, +5.08% on the session.

Against the IVW growth benchmark the position is +4.28% over the forecast window.

The read is built from 15 underlying insights — 6 bullish and 9 bearish.

Agreement across those insights is 60%.

Twist Bioscience has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Twist Bioscience in the 23rd percentile on return on equity, where 100 is best.

Twist Bioscience is classified under Health Care / Biotechnology, with a market capitalisation of $10.08B.

StockMap tracks Twist Bioscience as the 26th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Twist Bioscience ranks 22nd of 381 in the group, against a group median of -0.08.